HRT associated with reduced COVID deaths
A new Southampton study indicates that receiving hormone replacement therapy (HRT) within six months of a recorded diagnosis of COVID-19 is associated with a reduction in mortality from the disease.
The study, published in Family Practice and led by Dr Christopher Wilcox, investigated the association between hormone replacement therapy or combined oral contraception use, and the likelihood
They identified a group of 1,863,478 women from 465 general practices in England. There were 5451 COVID-19 cases within the cohort. Hormone replacement therapy was associated with a 78% reduction in all-cause mortality in COVID-19. of death in women with COVID-19.
Read more on the main University website.
Related Staff Member
Dr Christopher R Wilcox BSc (Hons), MBBCh, DCH
Dr Christopher Wilcox is a Wessex GP trainee, and a NIHR Academic Clinical Fellow at the University of Southampton.
Read more